Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-21

Clinical Trial Update: Observational Study of Tocilizumab in Participants With Rheumatoid Arthritis in Australia

View source ↗

Summary

An observational study of tocilizumab in Australian patients with rheumatoid arthritis has completed, with results posted in July 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-07-21